Nuclear Accumulation of Histone Deacetylase 4 (HDAC4) Exerts Neurotoxicity in Models of Parkinson’s Disease

Dauer W, Przedborski S (2003) Parkinson’s disease: mechanisms and models. Neuron 39(6):889–909 Schapira AH (2009) Neurobiology and treatment of Parkinson’s disease. Trends Pharmacol Sci 30(1):41–47. doi:10.1016/j.tips.2008.10.005 Sando R 3rd, Gounko N, Pieraut S, Liao L, Yates J 3rd, Maximov A (2012) HDAC4 governs a transcriptional program essential for synaptic plasticity and memory. Cell 151(4):821–834. doi:10.1016/j.cell.2012.09.037 Taniguchi M, Carreira MB, Smith LN, Zirlin BC, Neve RL, Cowan CW (2012) Histone deacetylase 5 limits cocaine reward through cAMP-induced nuclear import. Neuron 73(1):108–120. doi:10.1016/j.neuron.2011.10.032 Mielcarek M, Zielonka D, Carnemolla A, Marcinkowski JT, Guidez F (2015) HDAC4 as a potential therapeutic target in neurodegenerative diseases: a summary of recent achievements. Front Cell Neurosci 9:42. doi:10.3389/fncel.2015.00042 Fitzsimons HL (2015) The class IIa histone deacetylase HDAC4 and neuronal function: nuclear nuisance and cytoplasmic stalwart? Neurobiol Learn Mem 123:149–158. doi:10.1016/j.nlm.2015.06.006 Bertos NR, Wang AH, Yang XJ (2001) Class II histone deacetylases: structure, function, and regulation. Biochemistry and cell biology = Biochimie et biologie cellulaire 79(3):243–252 Haberland M, Montgomery RL, Olson EN (2009) The many roles of histone deacetylases in development and physiology: implications for disease and therapy. Nat Rev Genet 10(1):32–42. doi:10.1038/nrg2485 McKinsey TA, Zhang CL, Lu J, Olson EN (2000) Signal-dependent nuclear export of a histone deacetylase regulates muscle differentiation. Nature 408(6808):106–111. doi:10.1038/35040593 Wang AH, Kruhlak MJ, Wu J, Bertos NR, Vezmar M, Posner BI, Bazett-Jones DP, Yang XJ (2000) Regulation of histone deacetylase 4 by binding of 14-3-3 proteins. Mol Cell Biol 20(18):6904–6912 Mathias RA, Guise AJ, Cristea IM (2015) Post-translational modifications regulate class IIa histone deacetylase (HDAC) function in health and disease. Molecular & cellular proteomics : MCP 14(3):456–470. doi:10.1074/mcp.O114.046565 Backs J, Worst BC, Lehmann LH, Patrick DM, Jebessa Z, Kreusser MM, Sun Q, Chen L et al (2011) Selective repression of MEF2 activity by PKA-dependent proteolysis of HDAC4. J Cell Biol 195(3):403–415. doi:10.1083/jcb.201105063 Backs J, Song K, Bezprozvannaya S, Chang S, Olson EN (2006) CaM kinase II selectively signals to histone deacetylase 4 during cardiomyocyte hypertrophy. J Clin Invest 116(7):1853–1864. doi:10.1172/JCI27438 Mihaylova MM, Vasquez DS, Ravnskjaer K, Denechaud PD, Yu RT, Alvarez JG, Downes M, Evans RM et al (2011) Class IIa histone deacetylases are hormone-activated regulators of FOXO and mammalian glucose homeostasis. Cell 145(4):607–621. doi:10.1016/j.cell.2011.03.043 Vega RB, Harrison BC, Meadows E, Roberts CR, Papst PJ, Olson EN, McKinsey TA (2004) Protein kinases C and D mediate agonist-dependent cardiac hypertrophy through nuclear export of histone deacetylase 5. Mol Cell Biol 24(19):8374–8385. doi:10.1128/mcb.24.19.8374-8385.2004 Chen B, Cepko CL (2009) HDAC4 regulates neuronal survival in normal and diseased retinas. Science 323(5911):256–259. doi:10.1126/science.1166226 Li J, Chen J, Ricupero CL, Hart RP, Schwartz MS, Kusnecov A, Herrup K (2012) Nuclear accumulation of HDAC4 in ATM deficiency promotes neurodegeneration in ataxia telangiectasia. Nat Med 18(5):783–790. doi:10.1038/nm.2709 Miska EA, Karlsson C, Langley E, Nielsen SJ, Pines J, Kouzarides T (1999) HDAC4 deacetylase associates with and represses the MEF2 transcription factor. EMBO J 18(18):5099–5107. doi:10.1093/emboj/18.18.5099 Bolger TA, Yao TP (2005) Intracellular trafficking of histone deacetylase 4 regulates neuronal cell death. The Journal of neuroscience : the official journal of the Society for Neuroscience 25(41):9544–9553. doi:10.1523/JNEUROSCI.1826-05.2005 Takahashi-Fujigasaki J, Fujigasaki H (2006) Histone deacetylase (HDAC) 4 involvement in both Lewy and Marinesco bodies. Neuropathol Appl Neurobiol 32(5):562–566. doi:10.1111/j.1365-2990.2006.00733.x Lee VM, Trojanowski JQ (2006) Mechanisms of Parkinson’s disease linked to pathological alpha-synuclein: new targets for drug discovery. Neuron 52(1):33–38. doi:10.1016/j.neuron.2006.09.026 Simon-Sanchez J, Schulte C, Bras JM, Sharma M, Gibbs JR, Berg D, Paisan-Ruiz C, Lichtner P et al (2009) Genome-wide association study reveals genetic risk underlying Parkinson’s disease. Nat Genet 41(12):1308–1312. doi:10.1038/ng.487 Satake W, Nakabayashi Y, Mizuta I, Hirota Y, Ito C, Kubo M, Kawaguchi T, Tsunoda T et al (2009) Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson’s disease. Nat Genet 41(12):1303–1307. doi:10.1038/ng.485 Betarbet R, Sherer TB, MacKenzie G, Garcia-Osuna M, Panov AV, Greenamyre JT (2000) Chronic systemic pesticide exposure reproduces features of Parkinson’s disease. Nat Neurosci 3(12):1301–1306. doi:10.1038/81834 Tanner CM (2010) Advances in environmental epidemiology. Movement Disorders: Official Journal of the Movement Disorder Society 25(Suppl 1):S58–S62. doi:10.1002/mds.22721 Nieto M, Gil-Bea FJ, Dalfo E, Cuadrado M, Cabodevilla F, Sanchez B, Catena S, Sesma T et al (2006) Increased sensitivity to MPTP in human alpha-synuclein A30P transgenic mice. Neurobiol Aging 27(6):848–856. doi:10.1016/j.neurobiolaging.2005.04.010 Yu WH, Matsuoka Y, Sziraki I, Hashim A, Lafrancois J, Sershen H, Duff KE (2008) Increased dopaminergic neuron sensitivity to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in transgenic mice expressing mutant A53T alpha-synuclein. Neurochem Res 33(5):902–911. doi:10.1007/s11064-007-9533-4 Norris EH, Uryu K, Leight S, Giasson BI, Trojanowski JQ, Lee VM (2007) Pesticide exposure exacerbates alpha-synucleinopathy in an A53T transgenic mouse model. Am J Pathol 170(2):658–666. doi:10.2353/ajpath.2007.060359 Lee M, Hyun D, Halliwell B, Jenner P (2001) Effect of the overexpression of wild-type or mutant alpha-synuclein on cell susceptibility to insult. J Neurochem 76(4):998–1009 Dauer W, Kholodilov N, Vila M, Trillat AC, Goodchild R, Larsen KE, Staal R, Tieu K et al (2002) Resistance of alpha-synuclein null mice to the parkinsonian neurotoxin MPTP. Proc Natl Acad Sci USA 99(22):14524–14529. doi:10.1073/pnas.172514599 Giasson BI, Duda JE, Quinn SM, Zhang B, Trojanowski JQ, Lee VM (2002) Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein. Neuron 34(4):521–533 Feng L, Wang CY, Jiang H, Oho C, Mizuno K, Dugich-Djordjevic M, Lu B (1999) Differential effects of GDNF and BDNF on cultured ventral mesencephalic neurons. Brain Res Mol Brain Res 66(1–2):62–70 Garrido-Garcia A, Andres-Pans B, Duran-Trio L, Diez-Guerra FJ (2009) Activity-dependent translocation of neurogranin to neuronal nuclei. The Biochemical Journal 424(3):419–429. doi:10.1042/BJ20091071 Chawla S, Vanhoutte P, Arnold FJ, Huang CL, Bading H (2003) Neuronal activity-dependent nucleocytoplasmic shuttling of HDAC4 and HDAC5. J Neurochem 85(1):151–159 Paroni G, Cernotta N, Dello Russo C, Gallinari P, Pallaoro M, Foti C, Talamo F, Orsatti L et al (2008) PP2A regulates HDAC4 nuclear import. Mol Biol Cell 19(2):655–667. doi:10.1091/mbc.E07-06-0623 Shimizu E, Nakatani T, He Z, Partridge NC (2014) Parathyroid hormone regulates histone deacetylase (HDAC) 4 through protein kinase A-mediated phosphorylation and dephosphorylation in osteoblastic cells. J Biol Chem 289(31):21340–21350. doi:10.1074/jbc.M114.550699 Cho Y, Sloutsky R, Naegle KM, Cavalli V (2013) Injury-induced HDAC5 nuclear export is essential for axon regeneration. Cell 155(4):894–908. doi:10.1016/j.cell.2013.10.004 Ostrerova N, Petrucelli L, Farrer M, Mehta N, Choi P, Hardy J, Wolozin B (1999) Alpha-synuclein shares physical and functional homology with 14-3-3 proteins. The Journal of Neuroscience: the Official Journal of the Society for Neuroscience 19(14):5782–5791 Broide RS, Redwine JM, Aftahi N, Young W, Bloom FE, Winrow CJ (2007) Distribution of histone deacetylases 1-11 in the rat brain. Journal of Molecular Neuroscience: MN 31(1):47–58 Salian-Mehta S, Xu M, McKinsey TA, Tobet S, Wierman ME (2015) Novel interaction of class IIb histone deacetylase 6 (HDAC6) with class IIa HDAC9 controls gonadotropin releasing hormone (GnRH) neuronal cell survival and movement. J Biol Chem 290(22):14045–14056. doi:10.1074/jbc.M115.640482 Sen A, Nelson TJ, Alkon DL (2015) ApoE4 and Abeta oligomers reduce BDNF expression via HDAC nuclear translocation. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience 35(19):7538–7551. doi:10.1523/JNEUROSCI.0260-15.2015 Yang Y, Qin X, Liu S, Li J, Zhu X, Gao T, Wang X (2011) Peroxisome proliferator-activated receptor gamma is inhibited by histone deacetylase 4 in cortical neurons under oxidative stress. J Neurochem 118(3):429–439. doi:10.1111/j.1471-4159.2011.07316.x Mielcarek M, Landles C, Weiss A, Bradaia A, Seredenina T, Inuabasi L, Osborne GF, Wadel K et al (2013) HDAC4 reduction: a novel therapeutic strategy to target cytoplasmic huntingtin and ameliorate neurodegeneration. PLoS Biol 11(11):e1001717. doi:10.1371/journal.pbio.1001717 Majdzadeh N, Wang L, Morrison BE, Bassel-Duby R, Olson EN, D’Mello SR (2008) HDAC4 inhibits cell-cycle progression and protects neurons from cell death. Developmental Neurobiology 68(8):1076–1092. doi:10.1002/dneu.20637 Paroni G, Fontanini A, Cernotta N, Foti C, Gupta MP, Yang XJ, Fasino D, Brancolini C (2007) Dephosphorylation and caspase processing generate distinct nuclear pools of histone deacetylase 4. Mol Cell Biol 27(19):6718–6732. doi:10.1128/MCB.00853-07 Paroni G, Mizzau M, Henderson C, Del Sal G, Schneider C, Brancolini C (2004) Caspase-dependent regulation of histone deacetylase 4 nuclear-cytoplasmic shuttling promotes apoptosis. Mol Biol Cell 15(6):2804–2818. doi:10.1091/mbc.E03-08-0624 Wetsel WC, Khan WA, Merchenthaler I, Rivera H, Halpern AE, Phung HM, Negro-Vilar A, Hannun YA (1992) Tissue and cellular distribution of the extended family of protein kinase C isoenzymes. J Cell Biol 117(1):121–133 Khan TK, Sen A, Hongpaisan J, Lim CS, Nelson TJ, Alkon DL (2015) PKCε deficits in Alzheimer’s disease brains and skin fibroblasts. J Alzheimers Dis 43(2):491–509 Hongpaisan J, Sun MK, Alkon DL (2011) PKC epsilon activation prevents synaptic loss, Abeta elevation, and cognitive deficits in Alzheimer’s disease transgenic mice. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience 31(2):630–643. doi:10.1523/jneurosci.5209-10.2011 Feng SJ, Li DG, Li Y, Yang X, Han S, Li JF (2013) Insight into hypoxic preconditioning and ischemic injury through determination of nPKC epsilon-interacting proteins in mouse brain. Neurochem Int 63(2):69–79. doi:10.1016/j.neuint.2013.04.011 Sun MK, Hongpaisan J, Nelson TJ, Alkon DL (2008) Poststroke neuronal rescue and synaptogenesis mediated in vivo by protein kinase C in adult brains. Proc Natl Acad Sci USA 105(36):13620–13625. doi:10.1073/pnas.0805952105 Fujita M, Sugama S, Nakai M, Takenouchi T, Wei J, Urano T, Inoue S, Hashimoto M (2007) Alpha-synuclein stimulates differentiation of osteosarcoma cells: relevance to down-regulation of proteasome activity. J Biol Chem 282(8):5736–5748. doi:10.1074/jbc.M606175200